There is an unmet need for new, effective treatments for patients with chronic spontaneous urticaria (CSU) that does not respond to antihistamines. In this webinar, the faculty delve into the pathophysiology and review current guidelines, treatment targets, and mechanisms of action of emerging agents, and discuss the clinical data and potential roles for novel treatments in the management of CSU.
- Provider:Paradigm Medical Communications, LLC
- Activity Link: https://ce.paradigmmc.com/a/RITWDF
- Start Date: 2024-11-15 06:00:00
- End Date: 2024-11-15 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Novartis Corporation Pharmaceuticals - Amount: 149675.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest